ArticleJournal of pediatric gastroenterology and nutrition2026

The validated French CFAbd-Score reveals a lower burden of gastrointestinal symptoms in patients on Elexacaftor/Tezacaftor/Ivacaftor.

Isabelle Sermet-Gaudelus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.